Brain graphic About Neurology ReviewsFeatured IssuesEditorial BoardPublishing StaffAdvertising InformationSubscription InformationOnline CME from Clinicians GroupCareer Center

Search:
Sort by:


Neurology Reviews.Com

Vol. 8, No. 3
March 2000


Return to table of contents

 

LATE BREAKING NEUROLOGIC NEWS


Chlamydia pneumoniae does not appear to play a role in the development of multiple sclerosis, according to a report in the January 11 Neurology. Neither viable C pneumoniae nor C pneumoniae DNA was detected in the cerebrospinal fluid of any of the 99 patients with multiple sclerosis or other neurologic diseases who participated in the study. Furthermore, metronidazole, which was found to be effective in a previous case study, had no activity against C pneumoniae in vitro. Inconsistent methodology and cross-reactivity to other bacteria could explain the disparity in results. "It's much too soon to put multiple sclerosis patients on antibiotics for Chlamydia pneumoniae," said study author Margaret Hammerschlag, MD.

Older women with type 2 diabetes are at a higher risk for major cognitive decline, indicated a longitudinal population-based study of 682 white women. Having diabetes for more than 15 years was associated with a 57% to 114% greater risk of major cognitive decline. Women with diabetes had lower scores on three tests of cognitive function and experienced an accelerated cognitive decline over time, according to a report in the January 24 Archives of Internal Medicine. In an accompanying editorial, David Bennett, MD, noted that the cognitive decline described in this study is too small to be detected by clinicians on a case-by-case basis. However, treatments will develop from an improved understanding of the neurophysiologic association between diabetes and cerebrovascular disease, he predicted.

Spontaneous internal carotid artery dissection is rare but treatable in children, according to a research letter in the January 26 JAMA. A 13-year-old boy presented to an emergency department with a severe left-sided throbbing headache that had developed suddenly. A few hours later, he experienced right-side numbness and a tingling sensation that spread from his fingers to his arm. An MRI scan and angiogram revealed the dissection. The patient responded within 24 hours to anticoagulation and remained symptom-free one month later.

Temporary loss of the ability to sneeze is associated with lateral medullary syndrome, according to a report of four consecutive cases published in the January 25 Neurology. Each patient had unilateral infarction of the brain stem and cerebellum in the territory of the ipsilateral posterior inferior cerebellar artery. "The patient felt the ticklish feeling in his nose signaling a sneeze; the buildup would peter out before the explosive completion of the sneeze, leaving him feeling dissatisfied," said study author Mark Hersch, MD, PhD. "Some of my patients have been amazed and relieved to hear that other patients have experienced the same symptom."

Treating elderly hypertensive patients to reduce diastolic blood pressure to below 65 mm Hg may actually increase the risk of stroke, according to a prospective study published in the December issue of Hypertension. In treated hypertensive patients, a J-shaped relationship was found between blood pressure and the risk of stroke. Patients with a diastolic blood pressure less than 65 mm Hg were at a greater risk of stroke than patients in the 65 to 74 mm Hg range. A higher risk was associated with diastolic blood pressure of more than 75 mm Hg. The therapeutic goal of "the lower the better" may not be the optimal strategy for blood pressure management in the elderly, the authors concluded.

Individuals who grew up in small, suburban families during the early 20th century are at a lower risk for the development of Alzheimer's disease, according to a University of Washington study in the January 25 Neurology. Interviews with 393 patients and 377 control subjects indicated that the risk for developing Alzheimer's disease was 39% higher for those who grew up with five or more siblings, and that it was also higher for those who grew up in a city or on a farm. The areas of the brain that show the earliest signs of Alzheimer's disease—the hippocampal formation, intracortical association areas, and reticular formation—are the same areas that are the slowest to mature during childhood and adolescence, the authors wrote. The association of lower risk of Alzeimer's disease in small, suburban families could reflect the benefits of higher socioeconomic status—improved nutrition and less exposure to infectious disease—they concluded. The researchers also noted that number of siblings and area of residence were clearer demarcations of socioeconomic status in the early 20th century.

Enteroviral ribonucleic acids were found in the spinal cords of 15 of 17 patients with amyotrophic lateral sclerosis (ALS); however enteroviral ribonucleic acid is not conclusively implicated in the development of ALS, reported European investigators. Enteroviral ribonucleic sequences were detected in the spinal cords of 15 (88.3%) of the 17 ALS patients and in only one (3.4%) of the 29 controls. According to the report in the January 11 Neurology, enteroviral sequences were located in neuronal cell bodies of the anterior horns of the spinal cord, suggesting that the viral infection is somehow associated with the abnormal immunologic response and neuronal death observed in patients with ALS.

Adults who were born small for gestational age (SGA) are less likely to hold professional or managerial jobs than adults who were in the normal range of weight at birth. However, there are no long-term social or emotional consequences, according to the 26-year follow-up of the 1970 British Birth Cohort, published in the February 2 JAMA. The results of a questionnaire completed by 7,470 SGA and control adults indicate no differences between the birth-weight groups in years of education completed or hours of work performed weekly. Although SGA adults were as likely to be married and satisfied with life, "every effort should be made to provide SGA children with an enriched environment to minimize the long-term negative effects," the authors advised.

The increase in symptoms reported by Lyme disease patients is similar to that reported by controls, according to a longitudinal, community-based study in the February 2 JAMA. Although 69% of the 678 patients with suspected Lyme disease in the study reported difficulty performing daily activities and an increased frequency of symptoms such as pain and fatigue, very few (19%) attributed their symptoms to Lyme disease. Furthermore, the frequency of symptoms among a subset of patients with a confirmed diagnosis was similar to that of matched control subjects. "The prognosis for most patients with Lyme disease who receive conventional antimicrobial treatment is excellent," the authors concluded. In an accompanying editorial, Pierce Gardener, MD, warned that "without a serologic criterion standard, there is no valid way to address issues of asymptomatic or atypical infection for long-term outcomes." In this study, patients with suspected Lyme disease who reported increased symptoms did not meet the Centers for Disease Control case definition, thus suggesting that the entire spectrum of Lyme disease is not recognized, he said. More sensitive diagnostic tests are needed to avoid unwarranted use of antibiotics for the patient whose clinical presentation is nonspecific, he concluded.

Positioning or stimulation of respiration during sleep may contribute to the prevention of sudden unexpected death in epilepsy (SUDEP), according to a report in the February Journal of Neurology, Neurosurgery and Psychiatry. Although most SUDEP deaths are unwitnessed, in an evaluation of the circumstances that surround SUDEP, researchers identified and questioned 15 witnesses (11% of the sample). Twelve deaths were associated with convulsive seizures, one patient collapsed following a generalized seizure, one collapsed after an aura, and one died in a probable postictal state. Most subjects (12) had experienced respiratory difficulty, which supports the theory that both central and obstructive apnea may play an important role in SUDEP.

Brain activity is altered in the sleep-deprived, according to a functional MRI study in the February 10 issue of Nature. During verbal learning tests, the temporal lobe was activated in rested subjects but not in sleep-deprived subjects. The prefrontal cortex became more active as the subject's sense of sleepiness increased. Also, the parietal lobes were more active in subjects deprived of sleep. These changes in activity may reflect the brain's ability to compensate for the effects of sleep deprivation, the authors suggested.

The incidence of sleep disturbance in children is higher than expected, according to a study published in the February issue of Developmental and Behavioral Pediatrics. After questioning parents, children, and teachers, the researchers found that 37% of 494 school-age children had at least one sleep-related problem. Issues such as bedtime resistance, sleep anxiety, breathing difficulties, night waking, bedwetting, sleepwalking, and daytime sleepiness can have a negative impact on children's daily lives, the authors said.

Golf ball injuries may cause post-traumatic seizures without causing posttraumatic amnesia, skull fracture, or dural tear, according to authors who described four cases in the February Journal of Neurology, Neurosurgery and Psychiatry. Two patients experienced acute extradural or cortical hematoma, the third experienced a minor depressed fracture and contusion, and the fourth experienced localized intracranial hematoma. Golf balls are able to transmit a considerable amount of mechanical energy at a small site of impact, the researchers noted.

An FDA advisory committee recommended approval of Novantrone (mitoxantrone for injection concentrate) for the treatment of selected patients with multiple sclerosis. The FDA will consider the recommendation of the Peripheral and Central Nervous System Drugs Advisory Panel in its final review of the new drug application. In a phase III trial, treatment with Novantrone reduced the annual relapse rate by 65%, compared with placebo, in patients with worsening relapsing-remitting and secondary progressive multiple sclerosis. At six months, treated patients had a 64% reduction in 1-point Expanded Disability Status Scale deterioration.

—Shauna Kubose
Senior Associate Editor

Return to table of contents